Sorry IHDR I can't reply by PM, but that makes total sense financially and commercially. CKYS clearly has the 'niche' foresite to enter specific markets and to tie up with SQUM would be the icing on the cake! Looking at other Bio companies such as SFLK it does seem that CKYS is severely undervalued
For the record, I'm in for the speculative play but will add more subject to their financilas being announced.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.